Novartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 ...

The acquisition of Regulus Therapeutics, a California-based biotechnology company focused on microRNA therapies, by Novartis ...

The Nativity School hosted its 28th annual Cultural Day on April 11, a vibrant tradition that brings students and families ...

Team starts road trip with injury scare, as Tatis is hit in forearm by a pitch; Padres score three runs in eighth to turn ...

Arcor and its affiliates currently own 49% of the dairy company, while Mastellone Hermanos holds the majority.

Two and a half years after France’s competition authority handed Novartis and Roche a hefty fine for allegedly using abusive practices to boost sales of their eye disease drug Lucentis ...